Edwards Lifesciences Income from Continuous Operations 2010-2024 | EW
Edwards Lifesciences income from continuous operations for the twelve months ending September 30, 2024 was $1.549B, a 16.66% increase year-over-year.
- Edwards Lifesciences annual income from continuous operations for 2023 was $1.399B, a 8.05% decline from 2022.
- Edwards Lifesciences annual income from continuous operations for 2022 was $1.522B, a 1.25% increase from 2021.
- Edwards Lifesciences annual income from continuous operations for 2021 was $1.503B, a 82.55% increase from 2020.